Biodesix Inc. (BDSX)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX ) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Kyle Mikson - Canaccord Genuity Dan Brennan - TD Cowen Sung Ji Nam - Scotia Bank Bill Bonello - Craig-Hallum Thomas Flaten - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to Biodesix, Inc. Third Quarter 2024 Earnings Conference Call.
Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.12 per share a year ago.
Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript
Biodesix, Inc. (NASDAQ:BDSX ) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Chris Brinzey - IR Scott Hutton - CEO Robin Harper Cowie - CFO Conference Call Participants Andrew Brackmann - William Blair Thomas Flaten - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the Biodesix Q2 2024 Earnings Conference Call.
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.17 per share a year ago.
